Sign Up Now to Download a Free Research Report on
Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts
Having problems viewing PDF files? Impax Laboratories, Inc.
Impax Laboratories shares plunged 26 percent on volume of nearly 12 million shares traded Tuesday to close at $14.80 a share. The company announced that the FDA has completed its re-inspection of its Hayward manufacturing facility, and issued a new Form 483 with 12 observations, three of which were repeat observations from previous inspections.
Going forward ... (see research report)
Subscribe to News Feeds